Fri.Sep 18, 2020

article thumbnail

Seattle Genetics stays step ahead of rivals with bladder cancer data

Bio Pharma Dive

Data confirming the company's drug Padcev can extend the lives of bladder cancer patients should strengthen its position with regulators, although Immunomedics is close behind with a competing treatment.

Genetics 296
article thumbnail

Oncology DTC: Opportunities

World of DTC Marketing

IN SUMMARY: According to a Takeda Oncology report “for people diagnosed with multiple myeloma, there can be an abundance of information, which can lead to confusion around the next steps in their diagnosis and treatment plan. Particularly, there appears to be a disconnect between what they understand and what they want to know about the treatment journey that lies ahead.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In unexpected finding, Roche claims arthritis drug may have role in treating COVID-19

Bio Pharma Dive

Previous study findings from Roche and others had indicated the Swiss drugmaker's Actemra, and other drugs like it, weren't helping patients hospitalized with coronavirus disease.

Drugs 269
article thumbnail

FIP Calls for a focus on Pharmacy Remuneration

Pharma Mirror

The Hague – “A common concern among pharmacy associations worldwide is the long-term financial viability of professional services delivered by pharmacists. These concerns are first and foremost triggered by the impacts of continued price and margin cuts in dispensing of medicines and the non-allocation of funding in many settings for extended professional services and social.

Pharmacy 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Preparing for a decade of radical change in pharma

pharmaphorum

The pharmaceutical industry is at an inflection point, where ground-breaking innovation must be translated into transformational value for patients, healthcare professionals and society. Transformational value exists at the nexus of scientific innovation, patient-centricity, regulatory and reimbursement reform, digital technology and affordability, and refers, in part, to the extraordinary advances in science seen in recent years.

Marketing 117
article thumbnail

NanoViricides Nominates a Novel Candidate for COVID-19 Treatment

Pharma Mirror

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, today announced that it has nominated a clinical drug candidate for the treatment of COVID-19, thus further advancing its COVID-19 program closer to human clinical trials.

More Trending

article thumbnail

New patent for Boehringer Ingelheim drug OFEV

Drug Patent Watch

Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…. The post New patent for Boehringer Ingelheim drug OFEV appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 98
article thumbnail

Moderna broadens R&D scope with Vertex, Chiesi alliances

pharmaphorum

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. . The larger of the two deals is with Vertex and includes $75 million upfront for a project to apply Moderna’s mRNA and lipid nanoparticle (LNP) to the development of drugs to treat cystic fibrosis, with another $380 million in potential milestone payments.

article thumbnail

Babybel Products Can Now Be Recycled Thanks to TerraCycle Partnership

XTalks

Bel Group, the maker of Babybel, Laughing Cow and Boursin cheeses, is partnering with TerraCycle to guarantee the recyclability of the packaging of the tens of thousands of its products sold annually in Canada. Babybel products can now be recycled thanks to a new program that encourages consumers to participate in the recycling of products. In partnership with TerraCycle , which specializes in recycling materials that cannot be placed in the blue bin, Babybel packaging will be transformed and gi

article thumbnail

Patients’ Digital Health Awards opens for applications from patient-centric digital health projects

pharmaphorum

The Patients’ Digital Health Awards (PDHA) has begun welcoming entries for its 2020 contest, which places patients at the forefront of innovation. As part of a common effort to make healthcare be about patients, not technologies or companies, the Awards’ organisers – the Digital Health Academy and MSD Foundation – have made sure patients have an active role in the initiative.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Here’s Why General Mills Is Launching a Keto-Friendly Product Line

XTalks

General Mills has launched a new keto-friendly product line called :ratio, making it the company’s first attempt to target consumers following the diet. Keto food products are low in sugar and carbs, and it’s a diet trend that is favored by many consumers. The ketogenic product category is expected to grow 5.5 percent through 2027. Furthermore , the ketogenic diet market accounted to $9 million in 2018.

article thumbnail

NASA-NOAA satellite sees tropical depression 22 strengthening in gulf of Mexico

Scienmag

Credit: Credit: NASA Worldview, Earth Observing System Data and Information System (EOSDIS) NASA-NOAA’s Suomi NPP satellite provided an infrared image of Tropical Depression 22 in the Gulf of Mexico during the early morning hours of Sept. 18. TD22 is expected to become a tropical storm, according to the National Hurricane Center (NHC). NASA’s Night-Time View […].

article thumbnail

Roche’s Actemra cuts chances of COVID-19 ventilator use in phase 3 trial

pharmaphorum

Roche’s Actemra may help fight pandemic after all with phase 3 trial results showing it cut the chances of COVID-19 patients, mainly from higher risk minority ethnic backgrounds with pneumonia, progressing to mechanical ventilation or death. Actemra (tocilizumab), branded as RoActemra in some countries, is an already approved anti-inflammatory drug that Roche has been trying to repurpose to fight the respiratory symptoms caused by the disease.

Trials 97
article thumbnail

Undersea earthquakes shake up climate science

Scienmag

Credit: Caltech Despite climate change being most obvious to people as unseasonably warm winter days or melting glaciers, as much as 95 percent of the extra heat trapped on Earth by greenhouse gases is held in the world’s oceans. For that reason, monitoring the temperature of ocean waters has been a priority for climate scientists, […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

NICE u-turn sees Akcea's Waylivra win NHS funding

Pharma Times

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)

Drugs 118
article thumbnail

NASA estimates powerful hurricane Teddy’s extreme rainfall

Scienmag

Credit: Credit: NASA/NOAA/NRL Using a NASA satellite rainfall product that incorporates data from satellites and observations, NASA estimated Hurricane Teddy’s rainfall rates. Teddy is a major hurricane in the Central North Atlantic Ocean. On Sept. 18, NOAA’s National Hurricane Center (NHC) warned that Teddy remains a powerful hurricane over the Central Atlantic Ocean, and large […].

article thumbnail

BMS' Opdivo wins new NICE lung cancer backing

Pharma Times

The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC

Drugs 125
article thumbnail

Raids and bloody rituals among ancient steppe nomads

Scienmag

Credit: Tunnug 1 Research Project Ancient historiographers described steppe nomads as violent people dedicated to warfare and plundering. Little archaeological and anthropological data are however available regarding violence in these communities during the early centuries CE. In a new study in the American Journal of Physical Anthropology, an international team led by researchers from the […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Access to coronavirus tests should be ‘top priority’, says NHS Confederation director

Pharma Times

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

127
127
article thumbnail

Biologists create new genetic systems to neutralize gene drives

Scienmag

Two active genetics strategies help address concerns about gene-drive releases into the wild Credit: Ana Silva In the past decade, researchers have engineered an array of new tools that control the balance of genetic inheritance. Based on CRISPR technology, such gene drives are poised to move from the laboratory into the wild where they are […].

article thumbnail

Deciphera Presents Data from QINLOCK™ (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020

BioTech 365

– Strength of QINLOCK PFS and OS Benefit in INVICTUS Study Reinforced with Longer Follow-up Period – – QINLOCK Dose Escalation Upon Progression Offers Additional Clinically Meaningful PFS Benefit in Phase 1 Study – WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc.

74
article thumbnail

Stroke patients with COVID-19 have increased inflammation, stroke severity and death

Scienmag

This study of ischemic stroke patients is the first to associate the neutrophil-lymphocyte ratio in patients with COVID-19 and ischemic stroke and stroke severity. Credit: UAB BIRMINGHAM, Ala. – Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients […].

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Bayer’s Vitrakvi shows long-term efficacy in TRK fusion-positive cancers

Pharma Times

Tumour agnostic therapy demonstrates sustained efficacy

89
article thumbnail

Mental health in times of the pandemic

Scienmag

German National Academy of Sciences Leopoldina hosts international virtual panel discussion In May 2020, the United Nations warned that the COVID-19 pandemic has the seeds of a major mental health crisis if action is not taken. Social isolation, job and financial losses, uncertainty about the real impact of the crisis, and fear for physical well-being […].

article thumbnail

Covid: Can a 'circuit break' halt the second wave?

The Pharma Data

Image copyright. Reuters. Prime Minister Boris Johnson says the UK is “now seeing a second wave” of Covid-19. Expanding “local” restrictions mean more than 13 million people (one-fifth of the UK population) have extra curbs on their lives. And the surge in cases is not contained to just the hotspots, but is widespread across the UK.

article thumbnail

Study links rising stress, depression in US to pandemic-related losses, media consumption

Scienmag

UCI researchers suggest providing mental health services to those with the greatest need Irvine, Calif. – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. […].

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Coronavirus: Teacher writes about 'horrendous' Covid-19 battle

The Pharma Data

By Katy Lewis BBC News. Related Topics. Coronavirus pandemic. image copyright Karen Thorp. image caption Karen Thorp says she is “extremely happy to be alive” A teacher who spent six weeks in hospital with coronavirus has written a 3,000-word account of her experience on the advice of medics who treated her. Karen Thorp, 51, from St Albans, believes she caught the disease in March while attending choir practice.

Nurses 52
article thumbnail

Removal of a gene could render lethal poxviruses harmless

Scienmag

The removal of one gene renders poxviruses – a lethal family of viral infections that are known to spread from animals to humans – harmless, a new study in the journal Science Advances reports. During this ground-breaking study, scientists from the Spanish National Research Council and the University of Surrey investigated the immune response of […].

Gene 72
article thumbnail

New York files $2 billion lawsuit against J&J for downplaying risks of opioids in its marketing

The Pharma Data

Raysonho @ Open Grid Scheduler / Grid Engine. New York State is suing Johnson & Johnson in a lawsuit seeking $2 billion in damages for the company’s role in the opioid crisis. The lawsuit targets the opioid medication Duragesic, which is a patch that contains fentanyl which the FDA first approved in 1990. It claimed to relieve pain over the course of 72 hours without the need to keep taking maintenance doses.

article thumbnail

Mapping the decision-making pathways in the brain

Scienmag

Scientists reveal a new area of the brain that could shed light on how we make choices Credit: OIST Every day, we make hundreds of decisions. While most are small and inconsequential, like choosing what to eat or wear, others are more complex and involve weighing up potential costs and benefits, like deciding whether to […].

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.